Author

Lars Henrik Frich

Oslo University HospitalORCID 0000-0002-3968-0897Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Amanda PoissonnieriD· 1 shared Arild Holth· 1 shared Assia V. BassarovaiD· 1 shared Bjarne JohannesseniD· 1 shared Eivind Valen EgelandiD· 1 shared Else Marit InderbergiD· 1 shared Gunhild Mari MælandsmoiD· 1 shared Henrik JesperseniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amanda PoissonnierORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CD38hiCD19dim cells in lymph nodes predict favorable prognosis in patients with stage III melanoma receiving adjuvant PD-1-blockade

Ieva Ailte, Sudhir Kumar Chauhan, Lina Prasmickaite, Assia V. Bassarova, Amanda Poissonnier, Marike Feenstra, Marta Nyakas, Bjarne Johannessen, Truls Ryder, Robert Hermann, Lars Henrik Frich, Arild Holth, Else Marit Inderberg, Henrik Jespersen, Viví Ann Flørenes, , Eivind Valen Egeland

This study identifies CD38hiCD19dim cells in lymph nodes as a prognostic marker for improved outcomes in stage III melanoma patients receiving PD-1 blockade.

Frontiers in Oncology · May 4, 2026Peer-reviewedCancer Biology